Women have a higher proportion of key immune cells between puberty and menopause, which may be linked to the sex hormone ...

As we observe Endometriosis Awareness Month in March, let us take a look at 7 biotech companies advancing promising ...

They’re trending across social media as anti-aging miracles—but experts aren’t convinced. Here’s what science (and ...

Endometriosis affects approximately 1.5 million women in the UK, leading to chronic pain and fatigue as tissue similar to the ...

The new drug could provide relief for around 1,000 women in England, but 1.5 million in the UK suffer with the condition ...

Daily hormone combination pill is approved The National Institute for Health and Care Excellence has recommended relugolix combination therapy—a combination of relugolix, estradiol, and norethisterone ...

A new pill designed to revolutionise endometriosis treatment has been approved for use on the NHS. The combination drug, relugolix–estradiol–norethisterone (also known as relugolix combination therapy ...

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily ...

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

Discover the newly approved endometriosis pill, Ryeqo, by NHS England, an innovative treatment offering hope to women ...

FRANKFORT House Republicans cut off debate Friday night as Democrats begged them to reject a Senate provision that would end ...

"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative ...